ASX Listing Rules Appendix 3B - New Issue Announcement Application for Quotation of Additional Securities and Agreement Appendix 3B‌‌‌‌

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

New issue announcement, application for quotation of additional securities‌‌‌ and agreement‌

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

RESAPP HEALTH LIMITED

ABN

51 094 468 318

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1

+Class of +securities issued or to be issued

Ordinary Fully Paid Shares

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

1,312,500 Shares

3

Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid

+securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

1,312,500 Shares

4

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

If the additional +securities do not rank equally, please state:

  • the date from which they do

  • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

  • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Yes

5

Issue price or consideration

Shares issued on conversion of unlisted options at $0.026 per share

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

Exercise of unlisted options

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

Yes

6b

The date the security holder resolution under rule 7.1A was passed

30 November 2015

6c

Number of +securities issued without security holder approval under rule 7.1

Nil

+ See chapter 19 for defined terms.

Appendix 3B Page 2 04/03/2013

6d

Number of +securities issued with security holder approval under rule 7.1A

Nil

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

-

6f

Number of +securities issued under an exception in rule 7.2

1,312,500 Shares

6g

If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the

+issue date and both values. Include the source of the VWAP calculation.

Not applicable

6h

If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

Not applicable

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

Listing Rule 7.1 - 12,898,710 Listing Rule 7.1A - 58,521,085

7

+Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

9 June 2016

Number

+Class

8

Number and +class of all

+securities quoted on ASX (including the +securities in section 2 if applicable)

536,227,103

Fully paid ordinary shares

Number

+Class

55,312,500

57,187,499

38,437,500

55,312,500

4,125,000

937,500

5,250,000

5,000,000

5,000,000

10,000,000

3,000,000

2,000,000

4,500,000

1,866,667

Fully paid ordinary shares (escrowed to 2 July 2016)

Fully paid ordinary shares (escrowed to 14 July 2017)

Performance Shares converting on a 1:1 basis upon the achievement of milestone (escrowed to 14 July 2017)

Performance Shares converting on a 1:1 basis upon the achievement of milestone (escrowed to 2 July 2016)

Unlisted Options ($0.026; 31 Dec 2016)

Unlisted Options ($0.026; 31 Dec 2016) - escrowed to 26 June 2016

Unlisted Options ($0.026; 31 Dec 2016) - escrowed to 14 July 2017

Incentive Options ($0.025; 2 July 2020)

Incentive Options ($0.05; 2 July 2020)

Incentive Options ($0.10; 2 July 2020)

Incentive Options ($0.05; 22 September 2020)

Incentive Options ($0.10; 22 September 2020)

Unlisted Options ($0.28; 29 April 2019) escrowed for 12

months to 29 April 2017.

Unlisted Options ($0.30; 29 April 2019) escrowed for 12

months to 29 April 2017.

9 Number and +class of all

+securities not quoted on ASX (including the +securities in section 2 if applicable)

+ See chapter 19 for defined terms.

Appendix 3B Page 4 04/03/2013

ResApp Health Limited published this content on 10 June 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 20 June 2016 01:34:02 UTC.

Original documenthttp://www.resapphealth.com.au/wp-content/uploads/2016/06/1562398.pdf

Public permalinkhttp://www.publicnow.com/view/4299CD1F1608A41F55AE37186E38264D6D2A2062